Showing results (131-140 of 207) with videos related to

Sort By:
Pageof 21
Antimicrobial Agents and Chemotherapy|April 1, 1987
Pharmacokinetics of habekacin in patients with renal insufficiencyJ P Fillastre, A Leroy, G Humbert, et al.
Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research|August 5, 2000
Characterization of RNABP, an RNA binding protein that associates with RNase LF Le Roy, A Laskowska, M Silhol, et al.
Drugs Under Experimental and Clinical Research|January 1, 1992
Effects of ketoprofen (NSAID) on the pharmacokinetics of pefloxacin and ofloxacin in healthy volunteersJ P Fillastre, A Leroy, F Borsa-Lebas, et al.
European Journal of Clinical Pharmacology|January 1, 1983
Pharmacokinetic aspects of guanfacine withdrawal syndrome in a hypertensive patient with chronic renal failureJ R Kiechel, D Lavene, M Guerret, et al.
Drugs Under Experimental and Clinical Research|January 1, 1993
Pharmacokinetics of lamotrigine in patients with renal impairment: influence of haemodialysisJ P Fillastre, A M Taburet, A Fialaire, et al.
Clinical Pharmacokinetics|July 1, 1990
Disposition of fleroxacin, a new trifluoroquinolone, and its metabolites. Pharmacokinetics in elderly patientsA M Taburet, A Devillers, P Thomare, et al.
Presse Medicale (Paris, France : 1983)|October 26, 1988
[Pharmacokinetics of ceftazidime in healthy and renal failure subjects]A Leroy, J P Fillastre, G Humbert, et al.
Clinical Pharmacology and Therapeutics|August 1, 1989
Zidovudine disposition in patients with severe renal impairment: influence of hemodialysisE Singlas, J C Pioger, A M Taburet, et al.
Pathologie-Biologie|April 1, 1993
[Effect of ketoprofen on the pharmacokinetics of two fluoroquinolones in males]A Leroy, J P Fillastre, F Borsa-Lebas, et al.
Pageof 21